HEADER HYDROLASE 19-NOV-18 6N4E TITLE HPGDS COMPLEXED WITH A QUINOLINE-3-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: H-PGDS,GST CLASS-SIGMA,GLUTATHIONE S-TRANSFERASE, COMPND 5 GLUTATHIONE-DEPENDENT PGD SYNTHASE,GLUTATHIONE-REQUIRING COMPND 6 PROSTAGLANDIN D SYNTHASE,PROSTAGLANDIN-H2 D-ISOMERASE; COMPND 7 EC: 5.3.99.2,2.5.1.18; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPGDS, GSTS, PGDS, PTGDS2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET24 KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.M.SHEWCHUK,P.WARD REVDAT 3 13-MAR-24 6N4E 1 REMARK REVDAT 2 10-APR-19 6N4E 1 JRNL REVDAT 1 27-MAR-19 6N4E 0 JRNL AUTH D.N.DEATON,Y.DO,J.HOLT,M.R.JEUNE,H.F.KRAMER,A.L.LARKIN, JRNL AUTH 2 L.A.ORBAND-MILLER,G.E.PECKHAM,C.POOLE,D.J.PRICE, JRNL AUTH 3 L.T.SCHALLER,Y.SHEN,L.M.SHEWCHUK,E.L.STEWART,J.D.STUART, JRNL AUTH 4 S.A.THOMSON,P.WARD,J.W.WILSON,T.XU,J.H.GUSS,C.MUSETTI, JRNL AUTH 5 A.R.RENDINA,K.AFFLECK,D.ANDERS,A.P.HANCOCK,H.HOBBS, JRNL AUTH 6 S.T.HODGSON,J.HUTCHINSON,M.V.LEVERIDGE,H.NICHOLLS, JRNL AUTH 7 I.E.D.SMITH,D.O.SOMERS,H.F.SNEDDON,S.UDDIN,A.CLEASBY, JRNL AUTH 8 P.N.MORTENSON,C.RICHARDSON,G.SAXTY JRNL TITL THE DISCOVERY OF QUINOLINE-3-CARBOXAMIDES AS HEMATOPOIETIC JRNL TITL 2 PROSTAGLANDIN D SYNTHASE (H-PGDS) INHIBITORS. JRNL REF BIOORG. MED. CHEM. V. 27 1456 2019 JRNL REFN ESSN 1464-3391 JRNL PMID 30858025 JRNL DOI 10.1016/J.BMC.2019.02.017 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 79.2 REMARK 3 NUMBER OF REFLECTIONS : 20793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1025 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 962 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.30 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE SET COUNT : 56 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1628 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : -0.09000 REMARK 3 B33 (A**2) : 0.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.129 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.111 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.064 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.337 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1733 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1582 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2363 ; 1.273 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3667 ; 0.952 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 202 ; 4.891 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 81 ;33.368 ;24.074 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 288 ;12.889 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;19.535 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 259 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1889 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 362 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 199 REMARK 3 RESIDUE RANGE : A 201 A 201 REMARK 3 ORIGIN FOR THE GROUP (A): 3.814 18.450 -11.873 REMARK 3 T TENSOR REMARK 3 T11: 0.0045 T22: 0.0472 REMARK 3 T33: 0.0150 T12: -0.0121 REMARK 3 T13: -0.0039 T23: 0.0201 REMARK 3 L TENSOR REMARK 3 L11: 0.9309 L22: 0.0019 REMARK 3 L33: 1.2365 L12: -0.0357 REMARK 3 L13: -0.1316 L23: 0.0074 REMARK 3 S TENSOR REMARK 3 S11: -0.0031 S12: -0.0679 S13: 0.0069 REMARK 3 S21: 0.0013 S22: -0.0035 S23: -0.0027 REMARK 3 S31: -0.0087 S32: 0.0210 S33: 0.0067 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6N4E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000238158. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26009 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 28.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.63700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG6K, 0.05 M TRIS PH 8.5, 5% REMARK 280 GLYCEROL, 10 MM DTT, 1% 1,4 DIOXANE, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.99250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.99250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.79950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.38000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.79950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.38000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.99250 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.79950 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 36.38000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 46.99250 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.79950 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 36.38000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -46.99250 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 28 CD OE1 NE2 REMARK 470 GLU A 35 CG CD OE1 OE2 REMARK 470 LYS A 73 CE NZ REMARK 470 LYS A 107 CE NZ REMARK 470 LYS A 108 CE NZ REMARK 470 MET A 115 SD CE REMARK 470 ASN A 144 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 193 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 63 108.34 76.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GSH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KCD A 202 DBREF 6N4E A 1 199 UNP O60760 HPGDS_HUMAN 1 199 SEQADV 6N4E GLY A 0 UNP O60760 EXPRESSION TAG SEQRES 1 A 200 GLY MET PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG SEQRES 2 A 200 GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU SEQRES 3 A 200 ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP SEQRES 4 A 200 TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE SEQRES 5 A 200 PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER SEQRES 6 A 200 LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU SEQRES 7 A 200 ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA SEQRES 8 A 200 ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO SEQRES 9 A 200 TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE SEQRES 10 A 200 ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN SEQRES 11 A 200 ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE SEQRES 12 A 200 GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE SEQRES 13 A 200 CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU SEQRES 14 A 200 ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL SEQRES 15 A 200 GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG SEQRES 16 A 200 PRO GLN THR LYS LEU HET GSH A 201 20 HET KCD A 202 27 HETNAM GSH GLUTATHIONE HETNAM KCD 7-(DIFLUOROMETHOXY)-N-[TRANS-4-(2-HYDROXYPROPAN-2-YL) HETNAM 2 KCD CYCLOHEXYL]QUINOLINE-3-CARBOXAMIDE FORMUL 2 GSH C10 H17 N3 O6 S FORMUL 3 KCD C20 H24 F2 N2 O3 FORMUL 4 HOH *144(H2 O) HELIX 1 AA1 ARG A 12 ARG A 14 5 3 HELIX 2 AA2 ALA A 15 LEU A 25 1 11 HELIX 3 AA3 GLU A 35 ALA A 37 5 3 HELIX 4 AA4 ASP A 38 SER A 44 1 7 HELIX 5 AA5 GLN A 63 LYS A 73 1 11 HELIX 6 AA6 THR A 81 SER A 100 1 20 HELIX 7 AA7 LYS A 108 ASN A 123 1 16 HELIX 8 AA8 ASN A 123 GLY A 136 1 14 HELIX 9 AA9 THR A 147 LYS A 164 1 18 HELIX 10 AB1 HIS A 171 ILE A 184 1 14 HELIX 11 AB2 ILE A 184 ARG A 194 1 11 SHEET 1 AA1 4 GLU A 30 ILE A 34 0 SHEET 2 AA1 4 TYR A 4 PHE A 9 1 N LEU A 6 O GLU A 30 SHEET 3 AA1 4 ILE A 53 VAL A 56 -1 O GLU A 55 N LYS A 5 SHEET 4 AA1 4 LEU A 59 HIS A 62 -1 O LEU A 61 N LEU A 54 CISPEP 1 ILE A 51 PRO A 52 0 13.49 SITE 1 AC1 11 TYR A 8 ARG A 14 TRP A 39 LYS A 43 SITE 2 AC1 11 LYS A 50 ILE A 51 GLN A 63 SER A 64 SITE 3 AC1 11 ASP A 97 HOH A 356 HOH A 382 SITE 1 AC2 12 PHE A 9 GLY A 13 ARG A 14 GLN A 36 SITE 2 AC2 12 MET A 99 TRP A 104 TYR A 152 ILE A 155 SITE 3 AC2 12 CYS A 156 LEU A 199 HOH A 313 HOH A 319 CRYST1 65.599 72.760 93.985 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015244 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013744 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010640 0.00000